To gain an understanding of the molecular mechanisms of or arian cancer, we
analyzed 16 ovarian tumors from Jewish Israeli patients by comparative gen
omic hybridization: 12 invasive epithelial tumors (including three BRCA1 an
d one BRCA2 mutation carriers), 2 primary peritoneal carcinomatosis, I pseu
domyxoma peritoneii tumor, and 1 sertoli cell tumor. We similarly analyzed
1 normal ovary from a BRCA1 mutation carrier, and 3 metastases. The most co
mmon abnormalities in epithelial tumors rr-ere amplification of 8q22.1-ter
(8/12, 66.6%), 1q22-32.1 (5/22, 41.6%), 3q, 10p (4/12, 33.3% for each), and
deletions of 9q (5/22, 41.6%) and 16q21-24 (4/12, 33.3%). All 3 BRCA1 muta
tion carriers and 2 of 8 sporadic cases displayed 9q deletion, and 2 of 3 B
RCA1 mutation carriers, but none of the sporadic cases, had deletion of chr
omosome 19. The range of genetic changes in primary peritoneal tumors and e
pithelial of ovarian cancers nas similar, though the mean number of alterat
ions in the former rr as less (3.5/tumor versus 8/tumor). Our preliminary r
esults may indicate that inherited predisposition to ovarian cancer possibl
y entails preferential somatic deletions of chromosomes 9 and 19. (C) 2000
Elsevier Science Inc. All rights reserved.